EPA:ORP - Euronext Paris - Matif - FR001400NLM4 - Common Stock - Currency: EUR
ORP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 30 industry peers in the Health Care Providers & Services industry. While ORP is still in line with the averages on profitability rating, there are concerns on its financial health. ORP is not overvalued while it is showing excellent growth. This is an interesting combination.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.74% | ||
ROE | 71.82% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | 26.07% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.3 | ||
Debt/FCF | N/A | ||
Altman-Z | 0.39 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.6 | ||
Quick Ratio | 0.6 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 1.2 | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
EPA:ORP (7/2/2024, 5:28:19 PM)
12.465
+0.15 (+1.24%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 1.2 | ||
Fwd PE | N/A | ||
P/S | 0.38 | ||
P/FCF | N/A | ||
P/OCF | 5.42 | ||
P/B | 1.05 | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.74% | ||
ROE | 71.82% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | 26.07% | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.3 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | 8.78% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.6 | ||
Quick Ratio | 0.6 | ||
Altman-Z | 0.39 |